These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 32620344)
1. Short-term effects of atropine combined with orthokeratology (ACO) on choroidal thickness. Zhao W; Li Z; Hu Y; Jiang J; Long W; Cui D; Chen W; Yang X Cont Lens Anterior Eye; 2021 Jun; 44(3):101348. PubMed ID: 32620344 [TBL] [Abstract][Full Text] [Related]
2. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination. Hao Q; Zhao Q Int Ophthalmol; 2021 Sep; 41(9):2963-2971. PubMed ID: 33954859 [TBL] [Abstract][Full Text] [Related]
3. Change in subfoveal choroidal thickness secondary to orthokeratology and its cessation: a predictor for the change in axial length. Li Z; Hu Y; Cui D; Long W; He M; Yang X Acta Ophthalmol; 2019 May; 97(3):e454-e459. PubMed ID: 30288939 [TBL] [Abstract][Full Text] [Related]
4. Choroidal thickness and axial length changes in myopic children treated with orthokeratology. Li Z; Cui D; Hu Y; Ao S; Zeng J; Yang X Cont Lens Anterior Eye; 2017 Dec; 40(6):417-423. PubMed ID: 28935528 [TBL] [Abstract][Full Text] [Related]
5. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results. Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278 [TBL] [Abstract][Full Text] [Related]
6. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control. Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318 [TBL] [Abstract][Full Text] [Related]
7. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial. Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280 [TBL] [Abstract][Full Text] [Related]
8. Orthokeratology and Low-Intensity Laser Therapy for Slowing the Progression of Myopia in Children. Xiong F; Mao T; Liao H; Hu X; Shang L; Yu L; Lin N; Huang L; Yi Y; Zhou R; Zhou X; Yi J Biomed Res Int; 2021; 2021():8915867. PubMed ID: 33575355 [TBL] [Abstract][Full Text] [Related]
9. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results. Tan Q; Ng AL; Cheng GP; Woo VC; Cho P Curr Eye Res; 2019 Jun; 44(6):671-678. PubMed ID: 30632410 [No Abstract] [Full Text] [Related]
10. The Association of Choroidal Thickening by Atropine With Treatment Effects for Myopia: Two-Year Clinical Trial of the Low-concentration Atropine for Myopia Progression (LAMP) Study. Yam JC; Jiang Y; Lee J; Li S; Zhang Y; Sun W; Yuan N; Wang YM; Yip BHK; Kam KW; Chan HN; Zhang XJ; Young AL; Tham CC; Cheung CY; Chu WK; Pang CP; Chen LJ Am J Ophthalmol; 2022 May; 237():130-138. PubMed ID: 34942105 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive effects of orthokeratology and atropine 0.01% eye drops on slowing the progression of myopia. Zhou H; Zhao G; Li Y Clin Exp Optom; 2022 Jul; 105(5):520-526. PubMed ID: 34228946 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis. Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial. Yuan Y; Zhu C; Liu M; Zhou Y; Yang X; Zheng B; Li Z; Mao X; Ke B Trials; 2021 Dec; 22(1):863. PubMed ID: 34852833 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kaburaki T; Kakehashi A Sci Rep; 2020 Jul; 10(1):12750. PubMed ID: 32728111 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Clinical Efficacies of 0.01% Atropine and Orthokeratology in Controlling the Progression of Myopia in Children. Zhao Q; Hao Q Ophthalmic Epidemiol; 2021 Oct; 28(5):376-382. PubMed ID: 33472507 [No Abstract] [Full Text] [Related]
16. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial. Tan Q; Ng AL; Cheng GP; Woo VC; Cho P Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683 [TBL] [Abstract][Full Text] [Related]
17. Pattern of Axial Length Growth in Children Myopic Anisometropes with Orthokeratology Treatment. Long W; Li Z; Hu Y; Cui D; Zhai Z; Yang X Curr Eye Res; 2020 Jul; 45(7):834-838. PubMed ID: 31821058 [TBL] [Abstract][Full Text] [Related]
18. Effects of Orthokeratology on Choroidal Thickness and Axial Length. Chen Z; Xue F; Zhou J; Qu X; Zhou X Optom Vis Sci; 2016 Sep; 93(9):1064-71. PubMed ID: 27273270 [TBL] [Abstract][Full Text] [Related]
19. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533 [TBL] [Abstract][Full Text] [Related]
20. Choroidal Thickness and Peripheral Myopic Defocus during Orthokeratology. Gardner DJ; Walline JJ; Mutti DO Optom Vis Sci; 2015 May; 92(5):579-88. PubMed ID: 25875682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]